These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1465031)

  • 1. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1992 Dec; 15(3):171-81. PubMed ID: 1465031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the use of medication for climacteric complaints in western Europe--II.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1994 May; 19(1):1-12. PubMed ID: 7935027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What women want from hormone replacement therapy: results of an international survey.
    Limouzin-Lamothe MA
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S21-4. PubMed ID: 8732469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The view of women aged 45-65 and their partners on aspects of the climacteric phase of life.
    Barentsen R; Foekema HA; Bezemer W; van Stiphout FL
    Eur J Obstet Gynecol Reprod Biol; 1994 Nov; 57(2):95-101. PubMed ID: 7859912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy--women's expectations and fears].
    Schultz-Zehden B
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the quality of life of women in the climacteric period].
    Skrzypulec V; Drosdzol A; Ferensowicz J
    Ginekol Pol; 2004 May; 75(5):373-81. PubMed ID: 15524411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.
    Schneider HP
    Int J Fertil Womens Med; 1997; 42 Suppl 2():365-75. PubMed ID: 9397384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutch general practitioners' attitudes towards the climacteric and its treatment.
    Stouthamer N; Visser AP; Oddens BJ; Beusmans G; Hoogland H; van Ree JW; Zuidweg J
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):147-52. PubMed ID: 8405643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):177-81. PubMed ID: 11975013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of estrogen replacement therapy and alternative therapies among Norwegian women aged 50-69].
    Dahle EJ; Lydersen S; Moen MH
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):318-20. PubMed ID: 16440039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin viscoelasticity during hormone replacement therapy for climacteric ageing.
    Piérard GE; Hermanns-Lê T; Paquet P; Piérard-Franchimont C
    Int J Cosmet Sci; 2014 Feb; 36(1):88-92. PubMed ID: 24152248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hormone replacement therapy: the Italian experience.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S13-5. PubMed ID: 8732467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.